BeOne Medicines (ONC) Operating Income Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.47% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -12.10% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 55.96% |
| 10 | BeOne Medicines | - | - | 1.35 Bn | 38.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.78% |
| Dec 31, 2025 | 33.79% |
| Sep 30, 2025 | 33.37% |
| Jun 30, 2025 | 30.06% |
| Mar 31, 2025 | 26.52% |
| Dec 31, 2024 | -34.20% |
| Sep 30, 2024 | 36.16% |
| Jun 30, 2024 | 39.12% |
| Mar 31, 2024 | -78.89% |
| Dec 31, 2023 | 7.50% |
| Sep 30, 2023 | 32.73% |
| Jun 30, 2023 | 3.88% |
| Mar 31, 2023 | 0.22% |
| Dec 31, 2022 | -6.49% |
| Sep 30, 2022 | -11.97% |
| Jun 30, 2022 | -72.35% |
| Mar 31, 2022 | -36.64% |
| Dec 31, 2021 | 38.88% |
| Sep 30, 2021 | -45.18% |
| Jun 30, 2021 | -42.80% |
| Mar 31, 2021 | 38.09% |
| Dec 31, 2020 | -67.17% |
| Sep 30, 2020 | -79.98% |
| Jun 30, 2020 | -83.56% |
| Mar 31, 2020 | -93.56% |
| Dec 31, 2019 | -118.36% |
| Sep 30, 2019 | -107.75% |
| Jun 30, 2019 | -51.61% |
| Mar 31, 2019 | -104.44% |
| Dec 31, 2018 | -119.99% |
| Sep 30, 2018 | -121.04% |
| Jun 30, 2018 | -191.76% |
| Mar 31, 2018 | -124.36% |